Table 2.
Identified key lipids and key metabolites.
| Key lipids | Key metabolites |
|---|---|
| DAG(16:0/18:1) | 1-carboxyethylisoleucine |
| DAG(16:0/18:3) | 4-cholesten-3-one |
| TAG(44:0)-FA(18:0) | 4-hydroxyglutamate |
| TAG(52:2)-FA(16:0) | α-ketoglutarate |
| TAG(52:2)-FA(18:1) | carotene diol (2) |
| TAG(52:2)-FA(18:2) | γ-glutamylglutamate |
| TAG(52:3)-FA(18:1) | glutamate |
| TAG(54:3)-FA(16:0) | glycerate |
| TAG(54:3)-FA(20:2) | isoleucine |
| TAG(54:3)-FA(20:3) | PC/3-MAPC* |
| TAG(54:4)-FA(16:0) | PSP** |
| TAG(54:4)-FA(20:3) | |
| TAG(54:5)-FA(16:0) |
*pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC).
**palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0).
Overview of key lipids and key metabolites with significant differential abundance between PLWH without MetS and PLWH with MetS. Listed in alphabetical order.